PROCTER & GAMBLE Co director receives equity award through a grant of 253 shares of common stock on June 9, 2026, reported as a grant, award, or other acquisition at a stated price of $0.00 per share. The award represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of additional Restricted Stock Units. Following this compensation-related grant, Christine M. McCarthy directly holds a total of 17,512.6591 shares of Procter & Gamble common stock.
PROCTER & GAMBLE Co director Christopher J. Kempczinski reported an equity award on a Form 4. On June 9, 2026, he acquired 258 Restricted Stock Units at $0.00 per unit under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents, bringing his reported holdings to 11,595.5466 shares/units.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez reported receiving an award of 320 shares of Common Stock in the form of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award was granted at no cash price as part of his equity compensation.
After this grant, Jimenez directly holds a total of 37,016.0703 shares of Common Stock, including prior awards and dividend equivalents credited in Restricted Stock Units.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Craig Arnold received an award of 202 shares of common stock in the form of Restricted Stock Units on 2026-06-09. The grant was made at $0.00 per share as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in additional RSUs.
After this compensation award, Arnold directly holds a total of 2,807.8441 shares. This is a routine equity grant rather than an open-market purchase or sale, and there are no remaining derivative positions disclosed in this filing.
PROCTER & GAMBLE Co executive Hesham Abd El Hak filed an initial Form 3 reporting his equity interests in the company. As CEO of Baby and Feminine Care, he reports direct ownership of 7,964.4034 shares of common stock and additional indirect holdings through retirement-related plans.
He also holds various stock options on P&G common stock, including grants covering 41,388 shares at an exercise price of $153.18 per share expiring in 2035 and 35,384 shares at $173.04 per share expiring in 2034. The filing lists multiple restricted stock unit and preferred stock-based retirement awards that are designed to settle in P&G common stock or cash under company benefit formulas.
Procter & Gamble Co/The Schedule 13G filing shows Vanguard Capital Management beneficially owned 174,810,071 shares of Common Stock, representing 7.52% of the class as of 03/31/2026. The filing lists sole voting power of 23,760,169 shares and sole dispositive power of 174,810,071 shares.
The filing states these holdings include securities held by Vanguard funds and managed accounts and notes the holdings reflect dispositive power exercised across Vanguard affiliates.
Procter & Gamble reported higher sales and earnings for the March 31, 2026 quarter and nine-month period. Quarterly net sales rose to $21.2 billion from $19.8 billion, with organic sales up 3% on modest volume growth, pricing and favorable foreign exchange.
Quarterly net earnings attributable to Procter & Gamble increased to $3.9 billion, and diluted EPS grew to $1.63 from $1.54. For the nine months, net sales reached $65.8 billion and net earnings attributable to Procter & Gamble were $13.0 billion, driving diluted EPS of $5.36 and Core EPS of $5.46.
Gross margin declined on mix, product and packaging investments, tariffs and higher restructuring, partly offset by productivity savings. Operating cash flow was $14.4 billion, with adjusted free cash flow of $11.7 billion and adjusted free cash flow productivity of 92%. The company is executing a $1.5–$2.0 billion restructuring plan and recorded a gain from dissolving the Glad joint venture, while noting potential recovery of about $200 million in previously paid U.S. tariffs.
The Procter & Gamble Company reported third-quarter fiscal 2026 results showing modest growth in a tougher environment. Organic sales rose 3%, driven by 2% higher volume and 1% pricing, with all 10 product categories and 7 regions growing organically.
Core earnings per share were $1.59, up 3% from the prior year, while currency-neutral core EPS of $1.54 was flat. Core gross margin was 50.0% and core operating margin 22.2%, both about 1 percentage point below last year, reflecting cost and mix pressures despite productivity savings.
Adjusted free cash flow productivity reached a strong 82%. For full-year fiscal 2026, the company maintained guidance for organic sales growth of 0%–4%, net sales growth of 1%–5%, core EPS growth of 0%–4%, and all-in EPS growth of 1%–6%, alongside plans for about $10 billion in dividends and $5 billion in share repurchases.
Procter & Gamble reported fiscal 2026 third-quarter net sales of $21.2 billion, up 7%, with organic sales up 3% on 2% higher volume and 1% pricing. Diluted EPS rose 6% to $1.63, aided by a gain from dissolving the Glad joint venture, while core EPS increased 3% to $1.59.
Operating cash flow was $4.0 billion and adjusted free cash flow $3.0 billion, for 82% adjusted free cash flow productivity. The company returned $3.2 billion to shareholders through $2.5 billion in dividends and over $600 million of buybacks, and recently extended its dividend growth streak to 70 consecutive years.
P&G maintained fiscal 2026 guidance for all-in sales growth of 1%–5% and organic sales growth of in-line to up 4%, and kept diluted EPS growth guidance at 1%–6% and core EPS growth at in-line to up 4%, but now expects EPS near the lower end of the ranges due to about $0.25 per-share headwinds from commodities, tariffs, interest and taxes. The company still plans around $10 billion in dividends and about $5 billion of share repurchases in fiscal 2026.
The Procter & Gamble Company announced that its Board of Directors declared an increased quarterly dividend of $1.0885 per share on its Common Stock and Series A and B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after May 15, 2026 to shareowners of record on April 24, 2026.
The company stated this dividend is a 3% increase from the prior quarterly dividend. P&G highlighted that it has paid a dividend for 136 consecutive years and has raised its dividend for 70 consecutive years, underscoring a long-standing commitment to returning cash to shareowners who value steady income.